ArticleFrontiers in pharmacology2025
Comparative effectiveness and pharmacological fingerprints of indobufen versus rivaroxaban in patients with chronic kidney disease: a single-center, real-world study.
Lijun Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.